HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Makoto Ohori Selected Research

M-VAC protocol

8/2011The efficacy and safety of gemcitabine plus cisplatin regimen for patients with advanced urothelial carcinoma after failure of M-VAC regimen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Makoto Ohori Research Topics

Disease

34Prostatic Neoplasms (Prostate Cancer)
03/2020 - 02/2002
29Neoplasms (Cancer)
01/2021 - 03/2003
10Margins of Excision
01/2018 - 11/2002
8Urinary Bladder Neoplasms (Bladder Cancer)
12/2016 - 10/2003
7Extranodal Extension
06/2016 - 11/2002
5Hydronephrosis
12/2016 - 05/2012
5Renal Cell Carcinoma (Grawitz Tumor)
02/2014 - 09/2008
4Carcinoma (Carcinomatosis)
01/2017 - 03/2004
2Carcinoma in Situ
05/2013 - 05/2012
2Neoplasm Metastasis (Metastasis)
08/2011 - 09/2008
2Rheumatoid Arthritis
06/2008 - 01/2007
2Experimental Arthritis
06/2008 - 01/2007
2Neurogenic Inflammation
09/2005 - 05/2005
2Adenocarcinoma
03/2004 - 07/2003
1Autoimmune Diseases (Autoimmune Disease)
06/2018
1Psoriasis (Pustulosis Palmaris et Plantaris)
06/2018
1Neutropenia
01/2017
1Hematuria
01/2017
1Sarcopenia
12/2016
1Pyuria
07/2015
1Non-Muscle Invasive Bladder Neoplasms
07/2015
1Surgical Wound Infection
10/2014
1Diabetes Mellitus
10/2014
1Vesicovaginal Fistula
05/2013
1Candidiasis (Moniliasis)
05/2013
1Cystitis
05/2013
1Urinary Incontinence
08/2012
1Fever (Fevers)
02/2012
1Renal Insufficiency (Renal Failure)
10/2011
1Seminoma
12/2009
1Sarcoma (Soft Tissue Sarcoma)
12/2009
1Arthritis (Polyarthritis)
01/2007
1Body Weight (Weight, Body)
01/2007
1Hypersensitivity (Allergy)
01/2007

Drug/Important Bio-Agent (IBA)

20Prostate-Specific Antigen (Semenogelase)IBA
01/2018 - 05/2002
6Hemoglobins (Hemoglobin)IBA
12/2016 - 08/2011
5C-Reactive ProteinIBA
12/2016 - 09/2010
3Cisplatin (Platino)FDA LinkGeneric
11/2015 - 12/2009
3Biological ProductsIBA
10/2003 - 07/2003
2AntibodiesIBA
06/2018 - 01/2007
2Docetaxel (Taxotere)FDA Link
01/2017 - 07/2010
2CholesterolIBA
06/2016 - 01/2014
2Hormones (Hormone)IBA
07/2010 - 02/2004
2Biomarkers (Surrogate Marker)IBA
01/2009 - 10/2004
2FR 180204IBA
06/2008 - 01/2007
26H,8H- 3,4- dihydropyrimido(4,5- c)(1,2)oxazin- 7- oneIBA
09/2007 - 10/2003
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2007 - 10/2005
2Cannabinoid Receptor AgonistsIBA
09/2005 - 05/2005
1B7-H1 AntigenIBA
01/2021
1Interleukin-12 (IL 12)IBA
06/2018
1CreatinineIBA
01/2017
1Serum AlbuminIBA
12/2016
1ABO Blood-Group SystemIBA
01/2015
1Blood Group Antigens (Blood Groups)IBA
01/2015
14-toluenesulfonyl fluoride (TSF)IBA
10/2014
1Coloring Agents (Dyes)IBA
05/2013
1Gentian Violet (Violet, Crystal)FDA Link
05/2013
1asparaginylendopeptidase (legumain)IBA
04/2013
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2013
1Anti-Bacterial Agents (Antibiotics)IBA
02/2012
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2011
1Methotrexate (Mexate)FDA LinkGeneric
08/2011
1GemcitabineFDA Link
08/2011
1EstramustineFDA Link
07/2010
1Hydrocortisone (Cortisol)FDA LinkGeneric
07/2010
1Phosphates (Orthophosphate)IBA
07/2010
1Etoposide (VP 16)FDA LinkGeneric
12/2009
1Bleomycin (Blenoxane)FDA LinkGeneric
12/2009
1AndrogensIBA
02/2009
1TenascinIBA
09/2008
1Extracellular Matrix ProteinsIBA
09/2008
1Dihydrotachysterol (AT 10)IBA
09/2007
1Flucytosine (Ancobon)FDA Link
08/2007
1Cytosine DeaminaseIBA
08/2007
1Collagen Type II (Type II Collagen)IBA
01/2007
1(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA
05/2005
1EnzymesIBA
03/2004
1EndostatinsIBA
03/2004
1Indicators and Reagents (Reagents)IBA
03/2004
1Therapeutic UsesIBA
03/2004
1Green Fluorescent ProteinsIBA
03/2004

Therapy/Procedure

29Prostatectomy (Retropubic Prostatectomy)
03/2019 - 07/2002
9Therapeutics
01/2020 - 10/2003
5Cystectomy
12/2016 - 05/2012
4Drug Therapy (Chemotherapy)
01/2017 - 12/2009
3Nephrectomy
02/2014 - 09/2010
2Conservative Treatment
03/2020 - 12/2010
2Radiotherapy
03/2019 - 11/2003
2Nephroureterectomy
01/2017 - 11/2015
2Transurethral Resection of Bladder
12/2016 - 05/2013
2Brachytherapy
04/2016 - 12/2010
2Intravesical Administration
05/2013 - 03/2004
1Castration
01/2017
1Neoadjuvant Therapy
11/2015
1Urinary Diversion (Ileal Conduit)
10/2014
1Lymph Node Excision (Lymph Node Dissection)
05/2014
1Combined Modality Therapy
02/2014
1Combination Drug Therapy (Combination Chemotherapy)
08/2011
1M-VAC protocol
08/2011
1Transurethral Resection of Prostate (TURP)
02/2009